December 13, 2024 - 17:51

University Health’s Dr. Amy Cobb joined KSAT anchors Steve Spriester and Myra Arthur to address a range of pressing health questions from viewers on Thursday. The interactive segment provided valuable insights into various health topics, including the diabetes medication Jardiance, the consumption of raw milk, and the challenges of dealing with vertigo.
Dr. Cobb explained how Jardiance works to help manage blood sugar levels in patients with type 2 diabetes, emphasizing its benefits and potential side effects. She also discussed the ongoing debate surrounding raw milk, highlighting the risks associated with its consumption and the importance of pasteurization in preventing foodborne illnesses.
In addition to these topics, Dr. Cobb offered practical advice for those suffering from vertigo, a condition that can significantly impact daily life. Viewers appreciated the opportunity to gain expert knowledge on these health issues, reinforcing the importance of seeking reliable information in managing personal health.
May 9, 2026 - 22:43
College of Pharmacy & Health Sciences confers 206 degrees - NewsThe Campbell University College of Pharmacy & Health Sciences held its spring commencement ceremony to honor the achievements of the Class of 2026. A total of 206 degrees were conferred during the...
May 9, 2026 - 02:40
California Becomes First State to Offer Free Diapers for Every NewbornCalifornia is set to launch a first-of-its-kind program that will provide free diapers to every newborn in the state. The initiative, which makes California the first state in the country to offer...
May 8, 2026 - 11:45
Maryland ranked high among states for public health preparedness, but could be doing moreMaryland continues to rank among the top states in the nation for its ability to handle public health emergencies, according to a recent analysis by a national health policy organization. The state...
May 7, 2026 - 18:47
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo NordiskThe arrival of the first generic versions of semaglutide in Canada is being watched closely as a potential turning point for Novo Nordisk`s dominance in the global weight-loss and diabetes market....